Advances in the Treatment of Myelodysplastic Syndromes: Expert Guidance for Clinical Practice

Get expert insights on the optimal multidisciplinary care of patients with MDS in 2020 with this series of concise interactive virtual presentations commentaries and a new mobile-friendly format for getting expert recommendations individualized to your specific patient scenario with CCO&rsquo s Interactive Decision Support Tool.

Share

Program Content

Activities

Luspatercept for Anemia in MDS
Integrating A New Therapy Into the Clinical Management of Anemia in MDS
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: October 14, 2020

Expires: October 13, 2021

Activities

Anemia in MDS Slides
How I Treat Anemia in MDS: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2021

Expires: January 18, 2022

Treating Lower Risk MDS
Novel Therapies for Lower Risk MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 15, 2021

Expires: January 14, 2022

Treating Higher Risk MDS: Slides
Management of Higher Risk MDS: Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 19, 2021

Expires: January 18, 2022

MDS With Thrombocytopenia
Evolving Treatment Options for Thrombocytopenic Patients With MDS
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 21, 2021

Expires: January 20, 2022

Faculty

cover img faculity

Guillermo Garcia-Manero, MD

Professor, Division of Cancer Medicine
Chief, Section of Myelodysplastic Syndromes
Division of Cancer Medicine
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Rami S. Komrokji, MD

Professor of Oncologic Sciences
Department of Oncologic Sciences
University of Florida
Senior Member/Clinical Director
Malignant Hematology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Bristol Myers Squibb